Skip to content
DFI Logo
Deater Foundation, Inc.
dedicated to funding hsan1 research to find a treatment and cure.
  • About
    • DFI’s Mission
    • About HSAN1
    • HSAN1’s Cause
    • Year In Review
  • Contact
  • Funding
  • Photo Gallery
  • Research
    • DFI Timeline/History
    • Newsletter Archive
    • Related Articles
    • MGH Symposiums
    • Additional Info
    • Related Links
    • Useful Tips/Products

Related Articles

  • Gantner et al. (2019) “Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy” The New England Journal of Medicine.
    • Supplemental Index
  • Tyynismaa (2019) “A Metabolic Vulnerability of Vision” The New England Journal of Medicine
  • Fridman, Vera et al. (2019) “Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1.” Neurology 92.4 (2019): e359-e370. Web. 21 Jan. 2019.
  • Harrison, Dunn & Campopiano (2018) – Sphingolipid biosynthesis in man and microbes
  • Ernst et al. (2015) – Novel HSAN1 Mutation in Serine Palmitoyltransferase Resides at a Putative Phosphorylation Site That is Involved in Regulating Substrate Specificity
  • Othman et al. (2015) – Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats
  • ResearchFridman et al. (2015) – Natural History and Biomarkers in Hereditary Sensory Neuropathy Type 1
  • Myers et al. (2014) – Mutations in the SPTLC1 Protein Cause Mitochondrial Structural Abnormalities and Endoplasmic Reticulum Stress in Lymphoblasts
  • Suh et al. (2014) – Early-Onset Severe Hereditary Sensory and Autonomic Neuropathy Type 1 with S331F SPTLC1 Mutation
  • Murphy et al. (2013) – HSAN1 Caused by a Novel Mutation in SPTLC2
  • Auer-Grumbach et al. (2013) – Mutations at Ser331 in the HSN Type I Gene SPTLC1 are Associated with a Distinct Syndromic Phenotype
  • Garofolo et al. (2011) – Oral L-serine supplementation reduces production of neurotoxic dSLs in mice and humans with HSAN1
  • Scherer et al. (2011) – The Debut of a Rational Treatment for an Inherited Neuropathy?
  • Rotthier et al. (2011) – Characterization of Two Mutations in SPTLC1 Subunit of SPT Associated with HSAN1
  • Rotthier et al. (2010) – Mutations in the SPTLC2 Subunit of SPT Cause HSAN1
  • Bertea et al. (2010) – DSBs as Plasma Markers in Diabetes Mellitus
  • Penno et al. (2010) – HSAN1 is Caused by the Accumulation of Two Neurotoxic Sphingolipids
  • Eichler et al. (2009) – Overexpression of WT SPT1 Lowers DSB Levels and Rescues Phenotype of HSAN1
  • McCampbell et al. (2005) – HSAN1 Mouse Model
  • Bejaoui et al. (2001) – SPTLC1 is Mutated in HSAN1
  • Bejaoui et al. (1999) – Genetic Linkage of HSAN1
  • Tocantins & Reimann (1939) – Perforating Ulcer

Deater Foundation, Inc.

  • Email
    deaterfoundation@yahoo.com
  • Address
    Box 255
    White Deer, PA 17887

Search This Site

Archived Posts

GuideStar Participant

Copyright © 2021 Deater Foundation, Inc.